Sana Biotechnology

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.

Richard Mulligan Ph.D

Vice Chairman

1 past transactions

Oscine Therapeutics

Acquisition in 2020
Oscine Therapeutics is a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.